Skip to content
healthcare.dev

Linagliptin and metformin hydrochloride

NDC 72205-408, Linagliptin and metformin hydrochloride, tablet, film coated, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-408
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208459
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LINAGLIPTIN2.5 mg/1
  • METFORMIN HYDROCHLORIDE850 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]

Package NDCNDC-11Package
72205-408-017220504080160 TABLET, FILM COATED in 1 BOTTLE (72205-408-01)
72205-408-0272205040802180 TABLET, FILM COATED in 1 BOTTLE (72205-408-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb

Use it

Look up 72205-408 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-408 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.